| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |